Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKCA | P17252 | 5/20 | 0.78 |
| ▸ | PRKCE | Q02156 | 2/20 | 0.78 |
| ▸ | PRKCQ | Q04759 | 2/20 | 0.78 |
| ▸ | PRKCD | Q05655 | 2/20 | 0.78 |
| ▸ | MAPT | P10636 | 1/20 | 0.69 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.69 |
| ▸ | LMNA | P02545 | 4/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.65 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.55 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.55 |
| ▸ | MEN1 | O00255 | 1/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL821827 | 1.00 | PRKCA (0.78) | PRKCAPRKCEPRKCQPRKCDMAPT | |
| SCHEMBL4261284 | 0.98 | PRKCA (0.75) | PRKCAPRKCEPRKCQPRKCDMAPT | |
| SCHEMBL30531674 | 0.90 | ALDH1A1 (0.82) | PRKCAPRKCEPRKCQPRKCDMAPT | |
| SCHEMBL30597600 | 0.90 | ALDH1A1 (0.82) | PRKCAPRKCEPRKCQPRKCDMAPT | |
| SCHEMBL6437297 | 0.89 | PRKCA (0.74) | PRKCAPRKCEPRKCQPRKCDMAPT | |
| SCHEMBL868973 | 0.88 | PRKCA (0.78) | PRKCAPRKCEPRKCQPRKCDMAPT | |
| SCHEMBL23992003 | 0.88 | PRKCA (1.00) | PRKCAPRKCEPRKCQPRKCDMAPT | |
| SCHEMBL7061646 | 0.88 | PRKCA (1.00) | PRKCAPRKCEPRKCQPRKCDMAPT | |
| SCHEMBL8384466 | 0.88 | PRKCA (1.00) | PRKCAPRKCEPRKCQPRKCDMAPT | |
| SCHEMBL10426858 | 0.88 | PRKCA (1.00) | PRKCAPRKCEPRKCQPRKCDMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110287102-A1 | CHAIN EXTENDERS | POLYNOVO BIOMATERIALS PTY LIMITED (AU) | 2011-11-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110287102-A1 | CHAIN EXTENDERS | UMPS, PUF60, SMCHD1 | PRKCA 2539/4885PRKCE 2270/4885PRKCQ 3135/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.